- Report
- December 2024
- 200 Pages
Global
From €3339EUR$3,750USD£2,907GBP
- Report
- May 2025
- 100 Pages
Global
From €4229EUR$4,750USD£3,682GBP
- Report
- May 2025
- 106 Pages
Global
From €4229EUR$4,750USD£3,682GBP
- Report
- September 2025
- 150 Pages
Global
From €3962EUR$4,450USD£3,450GBP
- Report
- July 2025
- 342 Pages
Global
From €3962EUR$4,450USD£3,450GBP
- Report
- January 2025
- 250 Pages
Global
From €4451EUR$4,999USD£3,875GBP
- Report
- June 2025
- 400 Pages
Global
From €4407EUR$4,949USD£3,836GBP
- Report
- June 2025
- 400 Pages
Global
From €4407EUR$4,949USD£3,836GBP
- Report
- April 2025
- 188 Pages
Global
From €4448EUR$4,995USD£3,872GBP
- Report
- January 2025
- 178 Pages
Global
From €4448EUR$4,995USD£3,872GBP
- Report
- January 2025
- 102 Pages
Global
From €3500EUR$4,211USD£3,154GBP
- Report
- August 2025
- 150 Pages
Global
From €3428EUR$3,850USD£2,984GBP
- Report
- February 2025
- 150 Pages
Global
From €3428EUR$3,850USD£2,984GBP
€4318EUR$4,850USD£3,760GBP
From €6678EUR$7,500USD£5,814GBP
- Report
- June 2025
- 193 Pages
Global
From €4408EUR$4,950USD£3,837GBP
- Report
- May 2025
- 215 Pages
Global
From €4007EUR$4,500USD£3,488GBP
- Report
- April 2025
- 200 Pages
Global
From €3998EUR$4,490USD£3,481GBP
- Report
- February 2025
- 123 Pages
Asia Pacific
From €3072EUR$3,450USD£2,674GBP
- Report
- June 2025
- 88 Pages
North America
From €3072EUR$3,450USD£2,674GBP
- Report
- June 2025
- 80 Pages
Middle East, Africa
From €3072EUR$3,450USD£2,674GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more